نتائج البحث

Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database

• Authors : C. S. Karapetis; H. Liu; M. J. Sorich

Subjects: Science & Technology; PHASE-3; CHEMOTHERAPY

• Source: Br J CancerThe British journal of cancer

تفاصيل العنوان

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

• Authors : Liese Barbier; Paul Declerck; Steven Simoens

Subjects: Clinical Trials as Topic; Receptor, ErbB-2; EMC OR-01

• Source: Br J Cancer

تفاصيل العنوان

Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material

• Authors : Linder, S; Parrado, C; Falkmer, UG

Subjects: Medicin och hälsovetenskap

• Source: British journal of cancer. 76(1):54-59

تفاصيل العنوان

Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study

• Authors : Koutatsu Matsushima; Kensei Yamaguchi; Hideaki Bando

Subjects: Adult; Male; Proto-Oncogene Proteins B-raf

• Source: Br J Cancer

تفاصيل العنوان

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.

• Authors : Caiazza, F¹; McGowan, P M¹; Mullooly, M¹

• Source: British Journal of Cancer. 6/9/2015, Vol. 112 Issue 12, p1895-1903. 9p. 7 Graphs.

تفاصيل العنوان

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

• Authors : Viala, Marie; Vinches, Marie; Alexandre, Marie ...

Subjects: Clinical Decision-Making; [SDV.CAN]Life Sciences [q-bio]/Cancer; Antineoplastic Agents

• Source: Br J CancerBritish journal of cancer, vol. 118, no. 5, pp. 679-697British Journal of Cancer

تفاصيل العنوان

Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers.

• Authors : Harlé, A¹; Salleron, J²; Perkins, G³

• Source: British Journal of Cancer. 8/11/2015, Vol. 113 Issue 4, p680-685. 6p. 3 Charts, 1 Graph.

تفاصيل العنوان

FAT1: a potential target for monoclonal antibody therapy in colon cancer

• Authors : Giuseppe Viale; Chaojun Song; Boquan Jin

Subjects: Proto-Oncogene Proteins B-raf; 0301 basic medicine; Cancer Research

• Source: Br J CancerBritish Journal of Cancer 114 (2016): 40–51. doi:10.1038/bjc.2016.145info:cnr-pdr/source/autori:Piero Pileri, Susanna Campagnoli, Alberto

تفاصيل العنوان

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

• Authors : Nam H. Dang; Jérôme Alexandre; Taketo Yamada

Subjects: Adult; Male; Mesothelioma

• Source: Br J Cancer

تفاصيل العنوان

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

• Authors : Joseph Goodwill; Jennifer Garioch; Michelle Chin I Lo

Subjects: Proto-Oncogene Proteins B-raf; Antibodies, Monoclonal; Immunohistochemistry

• Source: Br J Cancer

تفاصيل العنوان